¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Extrapyramidal and movement disorder, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • unipolar disorder
    ´Ü±Ø¼ºÀå¾Ö, Ȭ±ØÀå¾Ö
  • vascular disorder
    Ç÷°üÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • self-defeating personality disorder
    ÀÚ±â¸ð¸êÀΰÝÀå¾Ö, ÀÚ±âÆÐ¹èÀΰÝÀå¾Ö, ÀÚ±âÇø¿ÀÀΰÝÀå¾Ö
  • separation anxiety disorder
    ºÐ¸®ºÒ¾ÈÀå¾Ö, ºÐ¸®ºÒ¾Èº´
  • sex limited disorder
    ÇѼºÀå¾Ö
  • sex-linked disorder
    ¹Ý¼ºÁúȯ, ¼ºµû¸§Áúȯ
  • sexual disorder
    ¼ºÀå¾Ö
  • sexual arousal disorder
    ¼ºÈïºÐÀå¾Ö
  • sexual aversion disorder
    ¼ºÇø¿ÀÀå¾Ö, ¼ºÇø¿Àº´
  • sexual desire disorder
    ¼º¿åÀå¾Ö
  • shared paranoid disorder
    °øÀ¯ÆíÁýÀå¾Ö, °øÀ¯ÆíÁýº´
  • sibling rivalry disorder
    µ¿±â°£°æÀïÀå¾Ö, µ¿±â°£°æÀﺴ
  • sleep disorder
    ¼ö¸éÀå¾Ö, ¼ö¸éº´
  • sleep-wake schedule disorder
    ¼ö¸é°¢¼ºÀÏÁ¤Àå¾Ö
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • somatic disorder
    ½ÅüÀå¾Ö
  • somatization disorder
    ½ÅüȭÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • nose and throat, ear [=ENT]
    À̺ñÀÎÈİú
  • nutritional excess and imbalance
    ¿µ¾ç°ú´Ù(ç½å×ΦÒý) ¹× ºÒ±ÕÇü(ÝÕгû¬)
  • oil and fat
    À¯Áö(êúò·).
  • on (and) off effect
    (ÀÚ±Ø)°³½ÃÁ¾·áÈ¿ °ú(ô±Ø°³½ÃÁ¾¿äÈ¿°ú).
  • on (and) off effect
    (ÀÚ±Ø)°³½ÃÁ¾·áÈ¿°ú(ô§Ð½ËÒã·ðûèçüùÍý).
  • one and one-half syndrome
    1 1/2 ÁõÈıº
  • pairing and subgrouping
    ¦Áö¿ò°ú ¼ÒÁý´ÜÈ­(á³ó¢Ó¥ûù)
  • palm and sole system of identification
    ¼öÀå Á·Àú È®Àιý(â¢íæðëî¼ü¬ìãÛö).
  • palm and sole system of identification
    ¼öÀåÁ·ÀúÈ®Àιý(â¢íæðëî¼ü¬ìãÛö).
  • palpation, percussion and auscultation
    ÃËÁø,ŸÁø,ûÁø(õºòàöèòàôéòà).
  • paraffin and wax
    ÆÄ¶óÇɰú ¿Î½º.
  • pepper-and-salt fundus
    ÈÄÃ߼ұݾÈÀú
  • perfusion and diffusion imaging
    °ü·ù È®»ê ¿µ»ó
  • pericarditis,bread and butter
    »§-¹öÅ͸ð¾ç(¡­Ù¼åÆ)
  • period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
PTSD Post-Traumatic Stress Disorder; ¿Ü»óÈÄ ½ºÆ®·¹½º Àå¾Ö
SAD Seasional Affective Disorder; °èÀý¼º Á¤µ¿ Àå¾Ö
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
ADCC acute disorder of cerebral circulation; antibody-dependent cell-mediated cytotoxicity
ADD acceptable daily dose; adduction; adenosine deaminase; attentional deficit disorder; average daily d...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
OCD Obsessive Compulsive Disorder
ODD Oppositional Defiant Disorder
ODS Osteogenic Disorder Shionogi
PD Panic Disorder
PDA Panic Disorder with Agoraphobia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neurotic disorder
    ½Å°æÁõÀû Àå¾Ö
  • neurovascular disorder
    ½Å°æ Ç÷°ü Àå¾Ö
  • non-vascular intracranial disorder
    ºñÇ÷°ü¼º µÎ°³³» Àå¾Ö
  • nonvascular intracranial disorder
    ºñÇ÷°ü¼º µÎ°³³» Àå¾Ö
  • nutritional disorder
    ¿µ¾ç ÀÌ»ó, ¿µ¾ç Àå¾Ö
  • obsessive-compulsive disorder
    °­¹Ú Àå¾Ö
  • order-disorder transformation
    ±ÔÄ¢-ºÒ±ÔÄ¢ º¯ÅÂ
    ¿ë¸Å ¿øÀÚ¿Í ¿ëÁú ¿øÀÚ°¡ ÀÓÀÇ·Î ¹è¿­Çϰí ÀÖ´Â ºÒ±ÔÄ¢ °ÝÀÚ¿¡¼­ ±ÔÄ¢ ¹Ù¸¥ ¹è¿­ÀÇ ±ÔÄ¢ °ÝÀÚ·Î º¯ÇÏ´Â º¯ÅÂ.
  • organic disorder
    ±âÁú Àå¾Ö
  • orofacial pain disorder
    ±¸°­ ¾È¸é ÅëÁõ Àå¾Ö, ±¸°­ ¾È¸é µ¿Åë Àå¾Ö
  • orthopedic disorder
    Á¤Çü¿Ü°úÀû Àå¾Ö
  • other craniofacial disorder
    ´Ù¸¥ µÎ°³ ¾È¸é Àå¾Ö
  • painful muscle disorder
    ÅëÁõ¼º ±ÙÀ° Àå¾Ö
  • pancreatic disorder
    ÃéÀå Àå¾Ö
  • paraprotein-producing disorder
    ÆÄ¶ó ÇÁ·ÎÅ×ÀÎ »ý¼º Àå¾Ö
  • parathyroid gland disorder
    ºÎ°©»ó¼± ÀÌ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
Gordon and Sweet stain <technique> A stain for reticulin, using acidified potassium permanganate, oxalic acid, iron alum, silver nitrate, formaldehyde, gold chloride, and sodium thiosulfate.
(05 Mar 2000)
Gougerot and Blum disease An eruption comprised of lichenoid papules variously pigmented from the haemosiderin of the associated purpura; found on the legs, usually in men over 40 years of age.
Synonym: Gougerot and Blum disease.
(05 Mar 2000)
chemical and pharmacologic phenomena Chemical, pharmacologic, and metabolic action and interaction of drugs.
(12 Dec 1998)
gram-negative aerobic rods and cocci <microbiology> A group of gram-negative bacteria consisting of rod- and coccus-shaped cells.
They are both aerobic (able to grow under an air atmosphere) and microaerophilic (grow better in low concentrations of oxygen) under nitrogen-fixing conditions but, when supplied with a source of fixed nitrogen, they grow as aerobes.
(12 Dec 1998)
gram-negative anaerobic straight, curved, and helical rods <microbiology> A group of anaerobic, rod-shaped bacteria that show up as pink (negative) when treated by the gram-staining method.
(12 Dec 1998)
mesonephric structures and their fates <radiology> Male female Tubules Epididymis Mesosalpinx Efferent ductules of testes Ducts Vas deferens Complete involution Seminal vesicles Ejaculatory ducts
(12 Dec 1998)
cholagogues and choleretics Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
(12 Dec 1998)
personnel staffing and scheduling The selection, appointing, and scheduling of personnel.
(12 Dec 1998)
personnel staffing and scheduling information systems Computer-based systems for use in personnel management in a facility, e.g., distribution of caregivers with relation to patient needs.
(12 Dec 1998)
growth and embryonic development Developmental processes from cell division to embryogenesis to postnatal growth and maturity.
(12 Dec 1998)
grunstein and hogness method The Grunstein and Hogness methodis a hybridisation lab technique in which whole, lysed (ruptured) bacterial colonies which have previously been blotted onto a nitrocellulose (or other) membrane are hybridised to a DNA probe.
(09 Oct 1997)
chondroitinases and chondroitin lyases <enzyme> Enzymes which catalyze the elimination of glucuronate residues from chondroitin a,b, and c or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-d-galactose 6-sulfate units of chondroitin sulfate.
Registry number: EC 4.2.2.-
(12 Dec 1998)
gyrate atrophy of choroid and retina A slowly progressive atrophy of the choriocapillaris, pigmentary epithelium, and sensory retina, with irregular confluent atrophic areas and an associated ornithinuria; autosomal recessive inheritance; due to a deficiency of ornithine d-aminotransferase.
(05 Mar 2000)
pharmacy and therapeutics committee An advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department.
(12 Dec 1998)
Rowntree and Geraghty test An obsolete test for renal function; after the patient has drunk a glass or two of water, 1 ml of a 0.6% solution of dye is injected hypodermically; the time between this injection and the appearance of a pink tinge in the urine as it falls into an alkaline solution is noted; the amount excreted in each of the next 2 hours is then estimated colourimetrically.
Synonym: Geraghty's test, phthalein test, red test, Rowntree and Geraghty test.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á